Lowy F, Pollack S, STEIGBIGEL N
Antimicrob Agents Chemother. 1984; 25(3):375-6.
PMID: 6721470
PMC: 185522.
DOI: 10.1128/AAC.25.3.375.
De Silva A, Bashi S, Basu Roy R
Br J Vener Dis. 1984; 60(2):132-3.
PMID: 6704697
PMC: 1046456.
DOI: 10.1136/sti.60.2.132-a.
Franczyk J, Goldner M
Br J Vener Dis. 1984; 60(2):133-4.
PMID: 6423210
PMC: 1046457.
DOI: 10.1136/sti.60.2.133.
Thin R, Barlow D, Eykyn S, Phillips I
Br J Vener Dis. 1983; 59(6):364-8.
PMID: 6416607
PMC: 1046238.
DOI: 10.1136/sti.59.6.364.
Talbot M, Spencer R, Kinghorn G
Br J Vener Dis. 1983; 59(4):277.
PMID: 6409347
PMC: 1046200.
DOI: 10.1136/sti.59.4.277.
Antimicrobial sensitivity of Neisseria gonorrhoeae. Comparison of penicillinase producing and non-penicillinase producing strains.
Herzog C, Ison C, Easmon C
Br J Vener Dis. 1983; 59(5):289-92.
PMID: 6311320
PMC: 1046210.
DOI: 10.1136/sti.59.5.289.
Spectinomycin as initial treatment for gonorrhea.
Coelho D, De Silva A, Roy R
Br Med J (Clin Res Ed). 1984; 289(6455):1383.
PMID: 6238647
PMC: 1443602.
DOI: 10.1136/bmj.289.6455.1383.
Rosoxacin in the treatment of uncomplicated gonorrhoea in men.
Panikabutra K, Ariyarit C, Chitwarakorn A, Saensanoh C
Br J Vener Dis. 1984; 60(4):231-4.
PMID: 6234966
PMC: 1046315.
DOI: 10.1136/sti.60.4.231.
Spectinomycin resistant gonococci.
Ison C, Littleton K, Shannon K, Easmon C, Phillips I
Br Med J (Clin Res Ed). 1983; 287(6408):1827-9.
PMID: 6231077
PMC: 1550036.
DOI: 10.1136/bmj.287.6408.1827.
Single dose oral amoxycillin 3 g with either 125 mg or 250 mg clavulanic acid to treat uncomplicated anogenital gonorrhoea.
Lawrence A, Shanson D
Genitourin Med. 1985; 61(3):168-71.
PMID: 4007860
PMC: 1011796.
DOI: 10.1136/sti.61.3.168.
Augmentin compared with amoxycillin in treating uncomplicated gonorrhoea.
Key P, Azadian B, Evans B
Genitourin Med. 1985; 61(3):165-7.
PMID: 3924814
PMC: 1011795.
DOI: 10.1136/sti.61.3.165.
Two regimens of sultamicillin in treating uncomplicated gonorrhoea.
Farthing C, Thin R, Smith S, Phillips I
Genitourin Med. 1985; 61(1):44-7.
PMID: 3002961
PMC: 1011754.
DOI: 10.1136/sti.61.1.44.
Susceptibility testing of Neisseria gonorrhoeae to penicillin and spectinomycin in a diagnostic laboratory.
Gill M, Ison C
J Clin Pathol. 1988; 41(9):978-82.
PMID: 2973474
PMC: 1141656.
DOI: 10.1136/jcp.41.9.978.
Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhoea (PPNG and non-PPNG infections): analysis of efficacy and patient preference.
Panikabutra K, Lee C, Ho B, BAMBERG P
Genitourin Med. 1988; 64(4):235-40.
PMID: 2971603
PMC: 1194223.
DOI: 10.1136/sti.64.4.235.
Plasmid profile of Neisseria gonorrhoeae in Nigeria and efficacy of spectinomycin in treating gonorrhoea.
Osoba A, JOHNSTON N, Ogunbanjo B, Ochei J
Genitourin Med. 1987; 63(1):1-5.
PMID: 2950045
PMC: 1193996.
DOI: 10.1136/sti.63.1.1.
In vitro activity of selected antimicrobial agents against penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains.
Waghorn D, Azadian B, Talboys C
Genitourin Med. 1986; 62(6):373-6.
PMID: 2950043
PMC: 1012001.
DOI: 10.1136/sti.62.6.373.
